Opinion: Contraceptive injections like Depo-Provera and Sayana Press have been widely used for decades, but mounting evidence and legal action suggest many women were never properly warned about rare but serious risks. The parallels with medical product liability scandals are striking—was this another case of mis-selling, or simply a failure of informed consent?
Caira is here to help you draft a clear statement or letter—just upload your medical files, photos of leaflets, or describe your symptoms for tailored support. Get answers in seconds and feel less anxious, knowing you have a legal companion ready to guide you through your options and next steps. Sign up in 30 seconds.
1. The Hidden Risks of Contraceptive Injections
For years, millions of women in the UK and worldwide have relied on Depo-Provera and Sayana Press for effective, convenient birth control. These injections, administered every three months, promised freedom from daily pills and, for many, relief from heavy or painful periods. But beneath the surface, a growing number of women have come forward with stories of devastating side effects—ranging from severe mood changes and weight gain to, in rare cases, benign brain tumours called meningiomas.
Recent research has brought these risks into sharper focus. A 2024 French study published in the BMJ found that women using injectable medroxyprogesterone acetate had a more than fivefold increased risk of developing meningiomas after a year of use. While the overall risk remains low, the consequences for those affected can be life-changing, involving major surgery, permanent disability, and psychological trauma.
2. What Does “Mis-selling” Mean in Medical Products?
In the world of medical products, “mis-selling” goes beyond simply being unhappy with a treatment. It’s about whether patients were given all the information they needed to make an informed choice—especially about rare but serious risks. Informed consent is a legal and ethical cornerstone of healthcare: patients must be told about significant risks, alternatives, and what to expect if things go wrong.
When warnings are missing, delayed, or downplayed, and when patients are not given a fair chance to weigh the risks and benefits, the line between informed consent and mis-selling becomes blurred. The Depo-Provera story echoes other medical product scandals, such as vaginal mesh and PIP breast implants, where lack of transparency and inadequate warnings led to widespread harm and legal action.
3. Arguments for Mis-selling: The Case Against the System
There are several strong arguments that contraceptive injections were mis-sold to many women:
Lack of clear warnings about serious risks: For years, product information did not mention the risk of meningiomas or long-term neurological harm. Many women only learned of these dangers after experiencing symptoms or reading about new research.
Marketing to young women without full disclosure: These injections were often recommended to teenagers and young adults, sometimes as a first-line option, without a full discussion of rare but severe side effects or the potential for long-term harm.
Label changes came too late: The manufacturer, Pfizer, only updated the patient information leaflet in 2024—after decades of widespread use and after some women had already suffered life-altering consequences.
Failure to provide informed consent or discuss alternatives: Many women report that they were not told about alternative contraceptive methods, or about the possibility that side effects could last for months after a single injection.
Let me know if you’re happy with the tone and content so far, and I’ll continue with the next three sections: arguments against mis-selling, the science and evidence, and legal action.
4. Arguments Against Mis-selling: The Case for the Defence
It’s important to acknowledge that many women have used Depo-Provera and Sayana Press without experiencing serious side effects. For some, these injections have provided reliable contraception, relief from painful periods, and improved quality of life. Medical professionals point out that the overall risk of meningiomas is extremely low—about one extra case per thousand women using Depo-Provera. Updated warnings and product information are now available, and doctors followed the best available guidelines at the time. Regulators acted promptly once new evidence emerged, and for most users, the benefits still outweigh the risks.
5. Science & Evidence: What We Know Now
Recent studies have changed the landscape. The BMJ’s 2024 French population study found a 5.6-fold increased risk of meningiomas after more than a year of use. JAMA Neurology reported a 143% higher risk of brain tumours among long-term users. Scientists believe the mechanism involves overstimulation of progesterone receptors in the meninges, triggering abnormal cell growth. The risk appears to rise with longer use, and is not seen with short-term use. While the absolute risk remains low, the consequences for those affected are severe—major surgery, loss of vision, and psychological trauma.
6. Legal Action & Regulatory Changes
Legal action is gathering pace. In the US, nearly 2,000 women are suing Pfizer, claiming they weren’t adequately warned about the risks. The company argues it tried to update the label but was blocked by the FDA, while plaintiffs say Pfizer could have done more to warn patients elsewhere. In the UK, several law firms are investigating claims, and regulatory bodies have updated product information to include warnings about meningioma. The legal landscape is complex, but UK claimants may have a clearer path to justice, as pre-emption does not apply and the Consumer Protection Act offers some protection for those harmed by defective medical products.
7. Evidence to gather for a claim for contraceptive injections
If you believe you’ve suffered harm from Depo-Provera or Sayana Press, collecting thorough evidence is crucial for any potential claim. Here’s what to gather:
Medical Records:
Documentation of all contraceptive injections received (dates, brands, batch numbers if possible).
Diagnosis of meningioma or other neurological conditions (e.g. idiopathic intracranial hypertension, memory loss, vision changes).
Records of any surgical procedures (e.g. brain surgery, radiotherapy, treatment for tumours).
Notes from consultations with GPs, specialists, or neurosurgeons regarding symptoms and diagnosis.
Imaging reports (MRI, CT scans) showing tumour location, size, and progression.
Consent and Product Information:
Copies of consent forms signed before receiving the injection.
Patient information leaflets provided at the time of treatment (especially versions before and after 2024 label updates).
Any written or verbal advice given by healthcare professionals about risks, alternatives, and side effects.
Correspondence and Communication:
Emails, letters, or messages exchanged with your GP, nurse, or specialist about symptoms, concerns, or follow-up.
Records of complaints or requests for further information from clinics or the manufacturer.
Personal Impact Statements:
Detailed descriptions of how your symptoms have affected daily life, work, family, and mental health.
Psychological effects (e.g. depression, anxiety, panic attacks, mood swings, paranoia, suicidal thoughts).
Physical effects (e.g. vision loss, facial disfigurement, scarring, headaches, seizures, memory impairment).
Impact on employment, relationships, and ability to carry out normal activities.
Symptoms to Document:
Persistent headaches, vision changes, or loss of sight.
Seizures, fainting, or neurological deficits.
Mood changes, depression, anxiety, paranoia, or suicidal ideation.
Unusual weight gain, bone density loss, or hormonal disturbances.
Prolonged or irregular bleeding, pain, or other menstrual changes.
Any diagnosis of benign brain tumours (meningiomas) or other neurological disorders.
Other Supporting Evidence:
Testimonies from family, friends, or colleagues who witnessed your symptoms or changes.
Evidence of psychological trauma, counselling, or therapy received.
Financial records showing loss of earnings or costs incurred due to illness or treatment.
The more comprehensive your evidence, the stronger your case will be. If you’re unsure what to collect, specialist solicitors can advise on what’s most relevant for your situation.
8. What Can Patients Do?
If you’re concerned about your experience with contraceptive injections, don’t stay silent. Keep all your documentation safe and seek medical advice if you have symptoms or worries. Contact a specialist solicitor for a free review—many work on a no win, no fee basis. Joining support groups or campaigns can help you connect with others in a similar position and stay informed about legal developments. Even if you’re not seeking compensation, sharing your story can help others make informed choices.
9. Comparison Table: Contraceptive Injection vs. Other Medical Product Scandals
Feature | Depo-Provera/Sayana Press | Vaginal Mesh | PIP Implants |
|---|---|---|---|
Product Type | Hormonal injection | Surgical mesh | Silicone |
Key Risk | Brain tumour, neuro | Chronic pain | Rupture |
Regulatory Response | Label update, warnings | Ban/restrict | Recall |
Legal Action | Class action, UK claims | Mass claims | Mass claims |
Informed Consent Issue | Yes | Yes | Yes |
10. Conclusion: The Case for Justice
The evidence is mounting: a lack of transparency and delayed warnings have left some women facing devastating consequences. While most users will never experience serious harm, those who do deserve answers, support, and—where appropriate—redress. If you believe you were mis-sold or inadequately warned about contraceptive injections, your voice matters. By coming forward, you can help ensure future patients are better protected and fully informed.
Disclaimer: This article is for information and discussion purposes only and does not constitute medical, financial or legal advice. If you have concerns about your health or believe you have suffered harm, please consult a qualified healthcare professional.
